Skip to main navigation Skip to search Skip to main content

Olaparib Use in Patients With Metastatic Breast Cancer Harboring Somatic BRCA1/2 Mutations or Mutations in Non-BRCA1/2, DNA Damage Repair Genes

  • Elaine M. Walsh
  • , Neha Mangini
  • , John Fetting
  • , Deborah Armstrong
  • , Isaac S. Chan
  • , Roisin M. Connolly
  • , Katie Fiallos
  • , Jennifer Lehman
  • , Raquel Nunes
  • , Dana Petry
  • , Jeffrey Reynolds
  • , Mirat Shah
  • , Karen L. Smith
  • , Kala Visvanathan
  • , Josh Lauring
  • , Ben H. Park
  • , Vered Stearns
  • , Antonio C. Wolff
  • Johns Hopkins University
  • Memorial Sloan-Kettering Cancer Center
  • University of Texas Southwestern Medical Center
  • Johnson & Johnson
  • Vanderbilt University

Research output: Contribution to journalArticlepeer-review

Fingerprint

Dive into the research topics of 'Olaparib Use in Patients With Metastatic Breast Cancer Harboring Somatic BRCA1/2 Mutations or Mutations in Non-BRCA1/2, DNA Damage Repair Genes'. Together they form a unique fingerprint.
Sort by

Biochemistry, Genetics and Molecular Biology